AstraZeneca Resumes US COVID-19 Vaccine Trial; J&J Prepares to Do the Same
AstraZeneca has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial as early as next week, the companies said on Friday.